 Theravance Biopharma Inc. shares TBPH, -6.73 slid 34 in premarket trade Wednesday, after the company announced a major overhaul of its business including reducing its headcount by about 75, or 270 jobs. The company is also cutting two long-term directors from its board and will focus its RD effort on its core respiratory assets. 